Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2024-05-30 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于因权益分派调整可转债转股价格的公告
Capital/Financing Update Classification · 100% confidence The document is an official announcement from Yifeng Pharmacy Chain Co., Ltd. regarding the adjustment of the conversion price of its convertible bonds due to equity distribution (dividends and stock dividends). It details the adjustment formula, the previous and new conversion prices, and the effective date of the adjustment. The document is short (1593 characters) and focuses on a specific capital structure change related to convertible bonds, not a full financial report or earnings release. It is not a report itself but an announcement about a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-05-30 Chinese
益丰药房关于召开2023年度暨2024年第一季度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of an investor performance briefing meeting for the 2023 annual and 2024 first quarter results. It provides details on the meeting time, location, participation method, and contact information. It explicitly states that the company has already published the 2023 annual report and 2024 first quarter report on April 29, 2024, and this meeting is to explain those results and answer investor questions. The document does not contain actual financial statements or detailed financial data but is an announcement of a meeting to discuss previously published reports. The document length is short (1698 characters), and it fits the pattern of an announcement rather than the report itself. Therefore, it should be classified as an Investor Presentation (IP) because it is a detailed presentation event for investors focusing on financials and strategy, not the report itself or a simple publication announcement (RPA).
2024-05-27 Chinese
益丰药房关于开立募集资金专户并签署募集资金专户存储四方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Yifeng Pharmacy Chain Co., Ltd. regarding the opening of a special account for raised funds and the signing of a four-party supervision agreement related to the management and use of funds raised from a convertible bond issuance. It details the approval from the China Securities Regulatory Commission, the amount raised, the establishment of the special account, the supervisory roles, and the terms of the agreement. The document is a formal public announcement about the company's capital raising and fund management arrangements, not a financial report or audit. It does not contain financial statements or earnings data but focuses on capital/financing update information related to the convertible bond issuance and fund management. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 3227 characters, which is consistent with an announcement rather than a full report.
2024-05-21 Chinese
益丰药房2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2023 Annual General Meeting (AGM) resolution announcement for Yifeng Pharmacy Chain Co., Ltd. It details the date and location of the AGM, attendance, voting results on various proposals including the 2023 annual report, financial statements, profit distribution, and appointment of auditors. The document includes voting percentages and legal compliance statements. It is a formal announcement of the resolutions passed at the AGM rather than the full annual report or financial statements themselves. The document length is 3345 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-05-20 Chinese
湖南启元律师事务所关于益丰大药房连锁股份有限公司2023年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 Annual General Meeting (AGM) of Yifeng Pharmacy Chain Co., Ltd. It details the legality and validity of the AGM's convening, attendance, voting procedures, and results. The document references the AGM specifically and does not contain financial statements or earnings data. It is not a report of financial performance but a legal opinion related to the AGM process. Therefore, it fits the category of AGM Information (AGM-R). The document length is under 5,000 characters and is a detailed legal opinion rather than a brief announcement, so it is not a Report Publication Announcement (RPA).
2024-05-20 Chinese
益丰药房2023年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2023 年年度股东大会会议资料" which translates to "2023 Annual General Meeting (AGM) Meeting Materials". It contains detailed agenda, meeting notices, and multiple proposals to be discussed and voted on at the AGM, including the board report, supervisory board report, annual report, financial report, and other corporate governance matters. The content is clearly the materials prepared for the shareholders' meeting rather than the actual annual report or financial statements themselves. The document length is about 15,000 characters, which is consistent with detailed AGM materials. There is no indication that this is a full annual report (10-K) or an earnings release (ER). It is not a voting results announcement (DVA) because it is the meeting materials, not the results. Therefore, the correct classification is AGM Information (AGM-R).
2024-05-10 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.